Showing 1 to 2 of 2 results


German Court Allows Unlicensed Drug Production for Rare Brain Tumor
A German court ruled that pharmacist Uwe-Bernd Rose can continue producing an unapproved drug containing ONC-201 for patients with a rare brain tumor, prioritizing their right to life and bodily integrity over strict regulatory adherence, despite legal challenges from an American company also develo...
German Court Allows Unlicensed Drug Production for Rare Brain Tumor
A German court ruled that pharmacist Uwe-Bernd Rose can continue producing an unapproved drug containing ONC-201 for patients with a rare brain tumor, prioritizing their right to life and bodily integrity over strict regulatory adherence, despite legal challenges from an American company also develo...
Progress
52% Bias Score

Lilly Intervenes in Lawsuit over Compounded Tirzepatide Drugs
Eli Lilly joined a lawsuit against the FDA, contesting the agency's October 2023 decision ending the shortage designation for its tirzepatide-based drugs (Zepbound and Mounjaro), impacting the legality of cheaper compounded alternatives. The FDA affirmed its decision in December, but the compounding...

Lilly Intervenes in Lawsuit over Compounded Tirzepatide Drugs
Eli Lilly joined a lawsuit against the FDA, contesting the agency's October 2023 decision ending the shortage designation for its tirzepatide-based drugs (Zepbound and Mounjaro), impacting the legality of cheaper compounded alternatives. The FDA affirmed its decision in December, but the compounding...
Progress
36% Bias Score
Showing 1 to 2 of 2 results